Alerts will be sent to your verified email
Verify Email
ACCENTMIC
|
Accent Microcell
|
Wanbury
|
Fredun Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.21 % | 58.3 % | 11.84 % |
|
5yr average Equity Multiplier
|
2.16 | -1.35 | 2.85 |
|
5yr Average Asset Turnover Ratio
|
1.47 | 1.54 | 1.08 |
|
5yr Avg Net Profit Margin
|
7.63 % | 5.09 % | 3.9 % |
|
Price to Book
|
4.41 | 14.58 | 5.63 |
|
P/E
|
26.0 | 20.1 | 27.11 |
|
5yr Avg Cash Conversion Cycle
|
85.19 Days | -103.0 Days | 175.29 Days |
|
Inventory Days
|
68.46 Days | 21.96 Days | 146.68 Days |
|
Days Receivable
|
81.86 Days | 61.39 Days | 142.46 Days |
|
Days Payable
|
72.23 Days | 194.51 Days | 112.95 Days |
|
5yr Average Interest Coverage Ratio
|
34.73 | 2.13 | 2.62 |
|
5yr Avg ROCE
|
24.49 % | -37.9 % | 22.71 % |
|
5yr Avg Operating Profit Margin
|
11.48 % | 7.72 % | 9.7 % |
|
5 yr average Debt to Equity
|
0.49 | 0.2 | 0.93 |
|
5yr CAGR Net Profit
|
47.1 % | n/a | 25.5 % |
|
5yr Average Return on Assets
|
10.07 % | 7.92 % | 4.18 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
55.44 % | 43.07 % | 43.06 % |
|
Share Pledged by Promoters
|
0.0 | 62.18 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.35 % | 3.23 % | -7.28 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Accent Microcell
|
Wanbury
|
Fredun Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|